Question · Q3 2025
Philip Shen from Roth Capital Partners sought clarification on the reported gross margin discrepancy between Canadian Solar's A-share subsidiary and the parent company, CSIQ. He also questioned how Canadian Solar plans to ramp up U.S. manufacturing amidst significant FEOC risks and asked about the company's potential exposure to retroactive duties from the 80 CBD reserve/Oxen case, inquiring if a balance sheet reserve would be necessary.
Answer
Dr. Shawn Qu, Chairman and CEO, and Xinbo Zhu, Senior VP and CFO, clarified that the 17.2% gross margin reported by CSIQ was an aggregate figure, significantly bolstered by Recurrent Energy's project sales, which achieved a 46.1% gross margin in Q3 2025. CSI Solar's manufacturing gross margin, including energy storage, was over 15%. Regarding U.S. manufacturing and FEOC risks, Dr. Qu reiterated that Canadian Solar believes it can meet OBBBA requirements through specific adjustments. On the 80 CBD/Oxen case, Dr. Qu stated that based on legal and audit advice, the company does not currently believe a reserve is required due to the ongoing and lengthy court process.